Page 101 - Read Online

Kozarov et al. Vessel Plus 2020;4:10 I http://dx.doi.org/10.20517/2574-1209.2019.31 Page 15 of 18

57. Yamazaki K, Honda T, Domon H, Okui T, Kajita K, et al. Relationship of periodontal infection to serum antibody levels to
periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease. Clin Exp Immunol
2007;149:445-52.
58. Sanchez-Torres D, Gutierrez-Bejarano D, Hurtado-Roca Y, Guallar-Castillon P, Muntner P, et al. Non-linear association of periodontal
pathogen antibodies with mortality. Int J Cardiol 2015;187:628-36.
59. Pussinen PJ, Paju S, Koponen J, Viikari JSA, Taittonen L, et al. Association of childhood oral infections with cardiovascular risk
factors and subclinical atherosclerosis in adulthood. JAMA Netw Open 2019;2:e192523.
60. Akhi R, Wang C, Nissinen AE, Kankaanpää J, Bloigu R, et al. Salivary IgA to MAA-LDL and oral pathogens are linked to coronary
disease. J Dent Res 2019;98:296-303.
61. Liljestrand JM, Paju S, Pietiäinen M, Buhlin K, Persson GR, et al. Immunologic burden links periodontitis to acute coronary
syndrome. Atherosclerosis 2018;268:177-84.
62. Silver JG, Martin AW, McBride BC. Experimental transient bacteraemias in human subjects with varying degrees of plaque
accumulation and gingival inflammation. J Clin Periodontol 1977;4:92-9.
63. Lockhart PB. An analysis of bacteremias during dental extractions. A double-blind, placebo-controlled study of chlorhexidine. Arch
Intern Med 1996;156:513-20.
64. Lockhart PB, Brennan MT, Kent ML, Norton HJ, Weinrib DA. Impact of amoxicillin prophylaxis on the incidence, nature, and
duration of bacteremia in children after intubation and dental procedures. Circulation 2004;109:2878-84.
65. Tomás I, Diz P, Tobías A, Scully C, Donos N. Periodontal health status and bacteraemia from daily oral activities: systematic review/
meta-analysis. J Clin Periodontol 2012;39:213-28.
66. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J
Periodontol 2000;71:1554-60.
67. Kozarov E, Sweier D, Shelburne C, Progulske-Fox A, Lopatin D. Detection of bacterial DNA in atheromatous plaques by quantitative
PCR. Microbes Infect 2006;8:687-93.
68. Toyofuku T, Inoue Y, Kurihara N, Kudo T, Jibiki M, et al. Differential detection rate of periodontopathic bacteria in atherosclerosis.
Surg Today 2011;41:1395-400.
69. Pyysalo MJ, Pyysalo LM, Pessi T, Karhunen PJ, Öhman JE. The connection between ruptured cerebral aneurysms and odontogenic
bacteria. J Neurol Neurosurg Psychiatry 2013;84:1214-8.
70. Pyysalo MJ, Pyysalo LM, Pessi T, Karhunen PJ, Lehtimäki T, et al. Bacterial DNA findings in ruptured and unruptured intracranial
aneurysms. Acta Odontol Scand 2016;74:315-20.
71. Gaetti-Jardim E Jr, Marcelino SL, Feitosa AC, Romito GA, Avila-Campos MJ. Quantitative detection of periodontopathic bacteria in
atherosclerotic plaques from coronary arteries. J Med Microbiol 2009;58:1568-75.
72. Calandrini CA, Ribeiro AC, Gonnelli AC, Ota-Tsuzuki C, Rangel LP, et al. Microbial composition of atherosclerotic plaques. Oral Dis
2014;20:e128-34.
73. Szulc M, Kustrzycki W, Janczak D, Michalowska D, Baczynska D, et al. Presence of periodontopathic bacteria DNA in atheromatous
plaques from coronary and carotid arteries. Biomed Res Int 2015;2015:825397.
74. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA Jr, Progulske-Fox A. Human atherosclerotic plaque contains viable invasive
Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005;25:e17-8.
75. Rafferty B, Jönsson D, Kalachikov S, Demmer RT, Nowygrod R, et al. Impact of monocytic cells on recovery of uncultivable bacteria
from atherosclerotic lesions. J Intern Med 2011;270:273-80.
76. Rafferty B, Dolgilevich S, Kalachikov S, Morozova I, Ju J, et al. Cultivation of Enterobacter hormaechei from human atherosclerotic
tissue. J Atheroscler Thromb 2011;18:72-81.
77. Cross KL, Campbell JH, Balachandran M, Campbell AG, Cooper SJ, et al. Targeted isolation and cultivation of uncultivated bacteria
by reverse genomics. Nat Biotechnol. 2019;37:1314-21.
78. Weise H, Naros A, Weise C, Reinert S, Hoefert S. Severe odontogenic infections with septic progress - a constant and increasing
challenge: a retrospective analysis. BMC Oral Health 2019;19:173.
79. Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for
disease causation and treatment with small-molecule inhibitors. Sci Adv 2019;5:eaau3333.
80. Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, et al. Oral infection with a periodontal pathogen accelerates early
atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003;23:1405-11.
81. Ezzahiri R, Stassen FR, Kurvers HA, van Pul MM, Kitslaar PJ, et al. Chlamydia pneumoniae infection induces an unstable
atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice. Eur J Vasc Endovasc Surg 2003;26:88-95.
82. Koren O, Spor A, Felin J, Fåk F, Stombaugh J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl
Acad Sci U S A 2011;108:4592-8.
83. Roth GA, Moser B, Huang SJ, Brandt JS, Huang Y, et al. Infection with a periodontal pathogen induces procoagulant effects in human
aortic endothelial cells. J Thromb Haemost 2006;4:2256-61.
84. Gibson FC, Hong C, Chou HH, Yumoto H, Chen J, et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in
apolipoprotein E-deficient mice. Circulation 2004;109:2801-6.
85. Liberto MC, Matera G, Lamberti AG, Barreca GS, Quirino A, et al. In vitro Bartonella quintana infection modulates the programmed
cell death and inflammatory reaction of endothelial cells. Diagn Microbiol Infect Dis 2003;45:107-15.
86. Potempa J, Banbula A, Travis J. Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol